Gastroenterology
Volume 136, Issue 2 , Pages 471-476, February 2009

Analysis of MUTYH Genotypes and Colorectal Phenotypes in Patients With MUTYH-Associated Polyposis

  • Maartje Nielsen

      Affiliations

    • Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands
    • Corresponding Author InformationAddress requests for reprints to: Maartje Nielsen, MD, PO Box 9600, 2333 ZA Leiden, The Netherlands. Phone: +31 71 5268033. fax: +31 71 5266749
  • ,
  • Mirjam C. Joerink - van de Beld

      Affiliations

    • Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands
  • ,
  • Natalie Jones

      Affiliations

    • Institute of Medical Genetics, School of Medicine, Cardiff University, Cardiff, Wales, United Kingdom
  • ,
  • Stefanie Vogt

      Affiliations

    • Institute of Human Genetics, University of Bonn, Bonn, Germany
  • ,
  • Carli M. Tops

      Affiliations

    • Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands
  • ,
  • Hans F.A. Vasen

      Affiliations

    • Department of Gastroenterology & Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands
  • ,
  • Julian R. Sampson

      Affiliations

    • Institute of Medical Genetics, School of Medicine, Cardiff University, Cardiff, Wales, United Kingdom
  • ,
  • Stefan Aretz

      Affiliations

    • Institute of Human Genetics, University of Bonn, Bonn, Germany
  • ,
  • Frederik J. Hes

      Affiliations

    • Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands

Received 5 August 2008; accepted 23 October 2008. published online 03 November 2008.

Background & Aims

Biallelic mutations in the base excision DNA repair gene MUTYH lead to MUTYH-associated polyposis (MAP) and predisposition to colorectal cancer (CRC). Functional studies have demonstrated significant differences in base recognition and glycosylase activity between various MUTYH mutations, notably for the 2 mutations most frequently reported in MAP patients: Y179C and G396D (previously annotated as Y165C and G382D). Our goal was to establish correlations between genotypes and colorectal phenotype of patients with MAP.

Methods

In this multicenter study, we analyzed genotype and phenotype data from 257 MAP patients. Data included age at presentation of MAP, polyp count, and the occurrence, location, and age at presentation of CRC.

Results

Patients with a homozygous G396D mutation or compound heterozygous G396D/Y179C mutations presented later with MAP and had a significantly lower hazard of developing CRC than patients with a homozygous Y179C mutation (P < .001). The mean ages of CRC diagnosis in patients were 58 years (homozygous G396D) and 52 years (compound heterozygous G396D/Y179C) versus 46 years (homozygous Y179C; P = .001, linear regression).

Conclusions

Our study identified the phenotypic effects of Y179C as relatively severe and of G396D as relatively mild. These clinical data are in accord with findings from in vitro functional assays. Genotypic stratification may become useful in the development of guidelines for counseling, surveillance, and management of families with MAP.

Abbreviations used in this paper: CRC, colorectal cancer, MAC, modified Astler–Coller, MAP, MUTYH-associated polyposis, 8-oxoG, 8-oxo-7,8-dihydro-2′-deoxyguanosine

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 M.N. and M.C.J.B. contributed equally to this work.

 J. R. Sampson has previously made intellectual property rights applications in relation to MYH sequence variants.

 The authors disclose the following: Supported by Cancer Research Wales, the Wales Office of Research and Development through the Wales Gene Park; the German Cancer Aid (grant 106244); and the Dutch Digestive Diseases Foundation (grant MWO 0355).

PII: S0016-5085(08)01894-5

doi:10.1053/j.gastro.2008.10.056

Gastroenterology
Volume 136, Issue 2 , Pages 471-476, February 2009